These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6628534)

  • 21. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
    Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL
    Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of (-) stepholidine on dopamine turnover in various brain regions].
    He YF; Huang KX; Jin GZ
    Sheng Li Xue Bao; 1995 Oct; 47(5):429-34. PubMed ID: 8711505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of systemic and intracerebroventricular domperidone treatment on striatal and hypothalamic dopaminergic neurons.
    Ferretti C; Benfenati F; Cimino M; Vantini G; Lipartiti M; Muccioli G; di Carlo R; Algeri S
    Med Biol; 1983; 61(6):331-6. PubMed ID: 6676604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus.
    Koulu M; Lappalainen J; Pesonen U; Hietala J; Syvälahti E
    Eur J Pharmacol; 1988 Oct; 155(3):313-6. PubMed ID: 3069483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.
    Karoum F; Egan MF
    Br J Pharmacol; 1992 Mar; 105(3):703-7. PubMed ID: 1628156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haloperidol and clozapine increase intraneuronal dopamine metabolism, but not gamma-butyrolactone-resistant dopamine release.
    Chrapusta SJ; Karoum F; Egan MF; Wyatt RJ
    Eur J Pharmacol; 1993 Mar; 233(1):135-42. PubMed ID: 8472742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dynamics of dopamine metabolism in the rat superior cervical, coeliac and mesenteric ganglia.
    Dalmaz Y; Favre R; De Haut M; Tavitian E; Peyrin L
    Eur J Pharmacol; 1985 Aug; 114(2):209-17. PubMed ID: 4043226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of synthesis-modulating nerve terminal autoreceptors on mesoamygdaloid and other mesolimbic dopamine neuronal populations.
    Kilts CD; Anderson CM; Ely TD; Nishita JK
    J Neurosci; 1987 Dec; 7(12):3961-75. PubMed ID: 3121804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic cocaine and rat brain catecholamines: long-term reduction in hypothalamic and frontal cortex dopamine metabolism.
    Karoum F; Suddath RL; Wyatt RJ
    Eur J Pharmacol; 1990 Sep; 186(1):1-8. PubMed ID: 2282931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethanol-stress interaction on dopamine metabolism in the medial prefrontal cortex.
    Fadda F; Mosca E; Meloni R; Gessa GL
    Alcohol Drug Res; 1985-1986; 6(6):449-54. PubMed ID: 3836690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of haloperidol administration on in vivo extracellular dopamine in striatum and prefrontal cortex after partial dopamine lesions.
    Bean AJ; Roth RH
    Brain Res; 1991 May; 549(1):155-8. PubMed ID: 1909923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine sulfoconjugation in the rat brain: regulation by monoamine oxidase.
    Buu NT
    J Neurochem; 1985 Aug; 45(2):470-6. PubMed ID: 3925084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
    Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
    Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo assessment of dopamine and norepinephrine release in rat neocortex: gas chromatography-mass spectrometry measurement of 3-methoxytyramine and normetanephrine.
    Wood PL; Kim HS; Altar CA
    J Neurochem; 1987 Feb; 48(2):574-9. PubMed ID: 3794722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesocortical dopamine neurons: high basal firing frequency predicts tyrosine dependence of dopamine synthesis.
    Tam SY; Elsworth JD; Bradberry CW; Roth RH
    J Neural Transm Gen Sect; 1990; 81(2):97-110. PubMed ID: 2363911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acidic dopamine metabolites in cortical areas of the rat brain: localization and effects of drug.
    Westerink BH; Korf J
    Brain Res; 1976 Aug; 113(2):429-34. PubMed ID: 953748
    [No Abstract]   [Full Text] [Related]  

  • 38. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
    Walters DE; Howard SG
    Eur J Pharmacol; 1990 Aug; 184(2-3):257-64. PubMed ID: 2150376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute effects of lithium on catecholamines, serotonin, and their major metabolites in discrete brain regions.
    Gottberg E; Grondin L; Reader TA
    J Neurosci Res; 1989 Mar; 22(3):338-45. PubMed ID: 2709448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoradiographic localization of dopamine D1 and D2 receptors in rat cerebral cortex following unilateral neurotoxic lesions.
    al-Tikriti MS; Roth RH; Kessler RM; Innis RB
    Brain Res; 1992 Mar; 575(1):39-46. PubMed ID: 1387031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.